These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

669 related items for PubMed ID: 17393216

  • 1. Dose-dependent effects of docosahexaenoic acid supplementation on blood lipids in statin-treated hyperlipidaemic subjects.
    Meyer BJ, Hammervold T, Rustan AC, Howe PR.
    Lipids; 2007 Mar; 42(2):109-15. PubMed ID: 17393216
    [Abstract] [Full Text] [Related]

  • 2. On the effects of dietary n-3 fatty acids (Maxepa) on plasma lipids and lipoproteins in patients with hyperlipidaemia.
    Simons LA, Hickie JB, Balasubramaniam S.
    Atherosclerosis; 1985 Jan; 54(1):75-88. PubMed ID: 3888229
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Dose-dependent action of atorvastatin in type IIB hyperlipidemia: preferential and progressive reduction of atherogenic apoB-containing lipoprotein subclasses (VLDL-2, IDL, small dense LDL) and stimulation of cellular cholesterol efflux.
    Guerin M, Egger P, Soudant C, Le Goff W, van Tol A, Dupuis R, Chapman MJ.
    Atherosclerosis; 2002 Aug; 163(2):287-96. PubMed ID: 12052475
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Influence of atorvastatin and simvastatin on apolipoprotein B metabolism in moderate combined hyperlipidemic subjects with low VLDL and LDL fractional clearance rates.
    Forster LF, Stewart G, Bedford D, Stewart JP, Rogers E, Shepherd J, Packard CJ, Caslake MJ.
    Atherosclerosis; 2002 Sep; 164(1):129-45. PubMed ID: 12119202
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Differential regulation of lipoprotein kinetics by atorvastatin and fenofibrate in subjects with the metabolic syndrome.
    Watts GF, Barrett PH, Ji J, Serone AP, Chan DC, Croft KD, Loehrer F, Johnson AG.
    Diabetes; 2003 Mar; 52(3):803-11. PubMed ID: 12606523
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Effects of fish oil concentrate on lipoproteins and apolipoproteins in familial combined hyperlipidemia.
    Tatò F, Keller C, Wolfram G.
    Clin Investig; 1993 Apr; 71(4):314-8. PubMed ID: 8471818
    [Abstract] [Full Text] [Related]

  • 13. Pitavastatin: novel effects on lipid parameters.
    Chapman MJ.
    Atheroscler Suppl; 2011 Nov; 12(3):277-84. PubMed ID: 22152282
    [Abstract] [Full Text] [Related]

  • 14. N-3 fatty acid supplementation mediates lipid profile, including small dense LDL, when combined with statins: a randomized double blind placebo controlled trial.
    Dogay Us G, Mushtaq S.
    Lipids Health Dis; 2022 Sep 01; 21(1):84. PubMed ID: 36050695
    [Abstract] [Full Text] [Related]

  • 15. Effects of atorvastatin on postprandial plasma lipoproteins in postinfarction patients with combined hyperlipidaemia.
    Boquist S, Karpe F, Danell-Toverud K, Hamsten A.
    Atherosclerosis; 2002 May 01; 162(1):163-70. PubMed ID: 11947910
    [Abstract] [Full Text] [Related]

  • 16. Effects of a low saturated fat, low cholesterol fish oil supplement in hypertriglyceridemic patients. A placebo-controlled trial.
    Harris WS, Dujovne CA, Zucker M, Johnson B.
    Ann Intern Med; 1988 Sep 15; 109(6):465-70. PubMed ID: 3166357
    [Abstract] [Full Text] [Related]

  • 17. Suppression by diets rich in fish oil of very low density lipoprotein production in man.
    Nestel PJ, Connor WE, Reardon MF, Connor S, Wong S, Boston R.
    J Clin Invest; 1984 Jul 15; 74(1):82-9. PubMed ID: 6736254
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Dietary fish oil increases conversion of very low density lipoprotein apoprotein B to low density lipoprotein.
    Huff MW, Telford DE.
    Arteriosclerosis; 1989 Jul 15; 9(1):58-66. PubMed ID: 2912422
    [Abstract] [Full Text] [Related]

  • 20. Effects of the cholesteryl ester transfer protein inhibitor torcetrapib on apolipoprotein B100 metabolism in humans.
    Millar JS, Brousseau ME, Diffenderfer MR, Barrett PH, Welty FK, Faruqi A, Wolfe ML, Nartsupha C, Digenio AG, Mancuso JP, Dolnikowski GG, Schaefer EJ, Rader DJ.
    Arterioscler Thromb Vasc Biol; 2006 Jun 15; 26(6):1350-6. PubMed ID: 16574893
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 34.